Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.
Tsou PS, Ali RA, Lu C, Sule G, Carmona-Rivera C, Lucotti S, Ikari Y, Wu Q, Campbell P, Gurrea-Rubio M, Maeda K, Fox SE, Brodie WD, Mattichak MN, Foster C, Tambralli A, Yalavarthi S, Amin MA, Kmetova K, Mazetto Fonseca B, Chong E, Zuo Y, Maile M, Imberti L, Caruso A, Caccuri F, Quaresima V, Sottini A, Kuhns DB, Fink DL, Castagnoli R, Delmonte O, Kenney H, Zhang Y, Magliocco M, Su HC, Notarangelo LD, Zemans RL, Mao-Draayer Y, Matei I, Salvatore M, Lyden DC, Kanthi Y, Kaplan MJ, Knight JS, Fox DA.
Tsou PS, et al. Among authors: fox da.
JCI Insight. 2025 Apr 1:e184975. doi: 10.1172/jci.insight.184975. Online ahead of print.
JCI Insight. 2025.
PMID: 40168094
Free article.